ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

RETRACTED: Gut Microbiota Mediates the Therapeutic Effect of Monoclonal Anti-TLR4 Antibody on Acetaminophen-Induced Acute Liver Injury in Mice (Retracted Article)

Sun, Xuewei; Cui, Qian; Ni, Juan; Liu, Xiaoguang; Zhu, Jin; Zhou, Tingting; Huang, HuaYing; OuYang, Ke; Wu, Yulong*; Yang, Zhan*南方医科大学; 1
Microbiology Spectrum2022-6DOI: 10.1128/spectrum.00647-22
5被引19阅读
引用收藏
分享

摘要

In this study, we found the monoclonal anti-Toll-like receptor 4 antibody can alleviate APAP-induced acute liver injury through the change of the gut microbiota, metabolic pathways, and gut barrier function. This work suggested the gut microbiota can be the therapeutic target of the APAP-induced acute liver injury, and we performed the fundamental research for further research. @@@ Acetaminophen (APAP) overdose is one of the most common causes of acute liver injury (ALI) in Western countries. Many studies show that the gut microbiota plays an important role in liver injury. Currently, the only approved treatment for APAP-induced ALI is N-acetylcysteine; therefore, it is essential to develop new therapeutic agents and explore the underlying mechanisms. We developed a novel monoclonal anti-Toll-like receptor 4 (TLR4) antibody (ATAB) and hypothesized that it has therapeutic effects on APAP-induced ALI and that gut microbiota may be involved in the underlying mechanism of ATAB treatment. Male C57BL/6 mice were treated with APAP and ATAB, which produced a therapeutic effect on ALI and altered the gut microbiota and their metabolic pathway, such as Roseburia, Lactobacillus, Akkermansia, and the fatty acid pathway, etc. Furthermore, we verified that purified short-chain fatty acids (SCFAs) could alleviate ALI. Moreover, a separate group of mice that received feces from the ATAB group showed less severe liver injury compared with the mice receiving feces from the APAP group. ATAB therapy also improved the gut barrier functions in mice and reduced the expression of protein zonulin. Our results revealed that gut microbiota plays an important role in the therapeutic effect of ATAB on APAP-induced ALI. IMPORTANCE In this study, we found the monoclonal anti-Toll-like receptor 4 antibody can alleviate APAP-induced acute liver injury through the change of the gut microbiota, metabolic pathways, and gut barrier function. This work suggested the gut microbiota can be the therapeutic target of the APAP-induced acute liver injury, and we performed the fundamental research for further research.

学科与关键词

关键词
gut microbiotaacetaminophenacute liver injuryTLR4
相关
加载中…
  • Gut Microbiota Mediates the Therapeutic Effect of Monoclonal Anti-TLR4 Antibody on Acetaminophen-Induced Acute Liver Injury in Mice
    Sun, Xuewei; Cui, Qian; Ni, Juan; Liu, Xiaoguang; Zhu, Jin; Zhou, Tingting; Huang, HuaYing; OuYang, Ke; Wu, Yulong*; Yang, Zhan*Microbiology Spectrum, 2023, 11(2).
  • Gut Microbiota and Chemical-Induced Acute Liver Injury
    Chen, Tao; Li, Rui; Chen, Peng*Frontiers in Physiology, 2021, 12: 688780.被引 23
  • Oridonin Alters Hepatic Urea Cycle via Gut Microbiota and Protects against Acetaminophen-Induced Liver Injury
    Hong, Mu-keng; Liu, Hai-hua; Chen, Gui-hong; Zhu, Jun-qing; Zheng, Song-yuan; Zhao, Di; Diao, Jianxing; Jia, Hui; Zhang, Ding-ding; Chen, Shi-xian*; Gao, Lei*; Li, Juan*Oxidative Medicine and Cellular Longevity, 2021, 2021.被引 10
查看全部 →

发表信息

论文状态
公开发表
期刊
Microbiology Spectrum
发表日期
2022-06
卷期
第 10 卷, 第 3 期
DOI
10.1128/spectrum.00647-22
期刊等级
2区
成果收录
SCIE
资助标注
National Key R&D Program of China [NSFC81871242]; [2018YFC1200603]

作者

  • S

    Sun, Xuewei (第一作者)

    binzhou med univ

  • C

    Cui, Qian

查看全部 10 位作者收起作者
  • N

    Ni, Juan

    1 · nanjing med univ

  • L

    Liu, Xiaoguang

    1 · southern med univ

  • Z

    Zhu, Jin

  • Z

    Zhou, Tingting

  • H

    Huang, HuaYing

    1 · nanjing med univ

  • O

    OuYang, Ke

    1 · nanjing med univ

  • W

    Wu, Yulong (通讯)

    binzhou med univ

  • Y

    Yang, Zhan (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417